Biosimilars: Patient and Physician Acceptability is the Fifth Hurdle to Market Competition
Loading...
Links to Files
Permanent Link
Collections
Author/Creator
Author/Creator ORCID
Date
2015
Type of Work
Department
Program
Citation of Original Publication
Lyles, A., (2015). Biosimilars: Patient and Physician Acceptability is the Fifth Hurdle to Market Competition. Generics and Biosimilars Initiative Journal. 4(1). DOI: 10.5639/gabij.2015.0401.002.
Rights
Abstract
Biosimilar products confront novel market authorization and post-marketing use hurdles. Existing evidence is insufficient to fully address physician and payer acceptability thresholds.